PI
BIO icon

Placemark Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Placemark Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$598K Sell
4,951
-158
-3% -$18.2K 0.01% 1093
2014
Q3 		$580K Sell
5,109
-443
-8% -$52.5K 0.01% 1125
2014
Q2 		$666K Buy
5,552
+882
+19% +$108K 0.01% 1057
2014
Q1 		$599K Sell
4,670
-2,162
-32% -$277K 0.01% 1043
2013
Q4 		$846K Buy
6,832
+332
+5% +$40.5K 0.01% 922
2013
Q3 		$765K Sell
6,500
-15
-0.2% -$1.77K 0.01% 918
2013
Q2 		$732K Buy
+6,515
New +$764K 0.02% 887

Other funds holding BIO

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Placemark Investments's BIO Position: Q4 2014 in Review

Placemark Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 3.1% in Q4 2014, selling an estimated $18.2K and leaving 4,951 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #1093.

Placemark Investments first reported a position in BIO in Q2 2013 and has held it in 7 quarters since. The position peaked at $846K in Q4 2013. 216 funds tracked by Wall St. Rank hold BIO as of Q4 2014.

  • Placemark Investments held 4,951 shares of Bio-Rad Laboratories Class A worth $598K as of Q4 2014.
  • Placemark Investments sold 158 Bio-Rad Laboratories Class A shares in Q4 2014, an estimated $18.2K.
  • Bio-Rad Laboratories Class A made up 0.01% of Placemark Investments's portfolio in Q4 2014, its #1093 holding.
  • Placemark Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's Bio-Rad Laboratories Class A position peaked at $846K in Q4 2013.
  • 216 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.